As of May 2024 NGM Biopharmaceuticals has a market cap of $0.12 Billion. This makes NGM Biopharmaceuticals the world's 7275th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.12 B | 80.9% |
2023 | $71.05 M | -82.68% |
2022 | $0.41 B | -70.29% |
2021 | $1.38 B | -35.43% |
2020 | $2.13 B | 72.72% |
2019 | $1.23 B |
On May 12th, 2024 the market cap of NGM Biopharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.89 B | 596.82% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $20.9 M | -83.74% | ๐บ๐ธ USA |